TORS-L: Transoral Robotic Surgery With C02 Laser
Transoral robotic surgery (TORS) has recently emerged as an alternative to comprehensive chemoradiation in the treatment of mucosal aerodigestive tract malignancies.
Designed for head and neck surgeons who have a high volume of cancer patients and are interested in adopting minimally invasive transoral approaches that combine robotic surgery and CO2 laser.
Advantages of TORS-L
- Increased control over collateral tissue damage compared to TORS-EC
- Delivers clear margins
- Increased preservation of surrounding tissue fields for margin assessment compared to TORS-EC
- Greater precision compared to TORS-EC